TY - JOUR
T1 - Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants
AU - Regeneron Genetics Center
AU - Genomics England Research Consortium
AU - UK Biobank
AU - HALT PKD
AU - DIPAK
AU - TAME PKD
AU - Genkyst Studies
AU - Mayo Clinic Biobank
AU - Jawaid, Tabinda
AU - Elbarougy, Doaa E.
AU - Lavu, Sravanthi
AU - Buia, Guillaume
AU - Senum, Sarah R.
AU - Olinger, Eric
AU - Yang, Hana
AU - McDonnell, Shannon K.
AU - Bublitz, Joshua T.
AU - Ma, Jun
AU - Audrézet, Marie Pierre
AU - Madsen, Charles D.
AU - Schauer, Rachel S.
AU - Baker, Tracy A.
AU - Gregory, Adriana V.
AU - Orr, Sarah E.
AU - Barroso-Gil, Miguel
AU - Neatu, Ruxandra
AU - Joli, Giancarlo
AU - Dahl, Neera K.
AU - Kline, Timothy L.
AU - Gillion, Valentine
AU - Dahan, Karin
AU - Jouret, Francois
AU - Perrone, Ronald D.
AU - Steinman, Theodore I.
AU - Peters, Dorien J.M.
AU - Gitomer, Berenice Y.
AU - Watnick, Terry J.
AU - Coto, Eliecer
AU - Chebib, Fouad T.
AU - Hogan, Marie C.
AU - Olson, Janet E.
AU - Larson, Nicholas B.
AU - Ars, Elisabet
AU - Halbritter, Jan
AU - Demoulin, Nathalie
AU - Torres, Vicente E.
AU - Sayer, John A.
AU - Cornec-Le Gall, Emilie
AU - Harris, Peter C.
AU - Ambrose, John C.
AU - Arumugam, Prabhu
AU - Bevers, Roel
AU - Bleda, Marta
AU - Boardman-Pretty, Freya
AU - Boustred, Christopher R.
AU - Brittain, Helen
AU - Caulfield, Mark J.
AU - Landsittel, D. P.
N1 - Publisher Copyright:
© 2025 Wolters Kluwer Health. All rights reserved.
PY - 2025/6/1
Y1 - 2025/6/1
N2 - BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is a common, inherited nephropathy often resulting in kidney failure. It is genetically heterogeneous; along with the major genes, PKD1 and PKD2, at least eight others have been suggested. ALG8 pathogenic variants have been associated with autosomal dominant polycystic liver disease and implicated in ADPKD, while ALG9 has been suggested as an ADPKD gene, but details of the phenotypes and penetrance are unclear.MethodsWe screened >3900 families with cystic kidneys and/or livers using global approaches to detect ALG8 or ALG9 pathogenic variants. In addition, population cohorts with sequence data (Genomics England 100K Genomics Project, UK Biobank, and Mayo Clinic Biobank [MCBB]) were screened for ALG8/ALG9 pathogenic variants.ResultsMulticenter screening of individuals with polycystic kidney and/or liver disease identified 51 (1.3%) ALG8 (7 multiplex) and 23 (0.6%) ALG9 (5 multiplex) families - frequencies that were approximately 10× and approximately 24× greater than nonpolycystic kidney disease controls. Analysis of individuals with polycystic kidney disease phenotypes in 100K Genomics Project, UK Biobank, and MCBB identified nine ALG8 (0.39%) and nine ALG9 (0.39%) families, an enriched frequency over controls. Two individuals had PKD1 and ALG8 pathogenic changes. Eighty-nine percent of individuals with ALG8 mutations with imaging in the entire MCBB had kidney cysts (50%, >10 cysts), with greater median kidney and liver cyst numbers than controls. For ALG9, 78% had kidney cysts (27%, >10 cysts). Individuals with ALG8 mutations typically had mild cystic kidneys with limited enlargement. Liver cysts were common (71%), with enlarged livers (>2L) found in 11 of 62 patients, although surgical intervention was rare. The ALG9 kidney phenotype was also of mild cystic kidneys, but enlarged livers were rare; for both genes, CKD or kidney failure were rare.ConclusionsALG8 and ALG9 are defined as cystic kidney/liver genes but with limited penetrance for lower eGFR.
AB - BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is a common, inherited nephropathy often resulting in kidney failure. It is genetically heterogeneous; along with the major genes, PKD1 and PKD2, at least eight others have been suggested. ALG8 pathogenic variants have been associated with autosomal dominant polycystic liver disease and implicated in ADPKD, while ALG9 has been suggested as an ADPKD gene, but details of the phenotypes and penetrance are unclear.MethodsWe screened >3900 families with cystic kidneys and/or livers using global approaches to detect ALG8 or ALG9 pathogenic variants. In addition, population cohorts with sequence data (Genomics England 100K Genomics Project, UK Biobank, and Mayo Clinic Biobank [MCBB]) were screened for ALG8/ALG9 pathogenic variants.ResultsMulticenter screening of individuals with polycystic kidney and/or liver disease identified 51 (1.3%) ALG8 (7 multiplex) and 23 (0.6%) ALG9 (5 multiplex) families - frequencies that were approximately 10× and approximately 24× greater than nonpolycystic kidney disease controls. Analysis of individuals with polycystic kidney disease phenotypes in 100K Genomics Project, UK Biobank, and MCBB identified nine ALG8 (0.39%) and nine ALG9 (0.39%) families, an enriched frequency over controls. Two individuals had PKD1 and ALG8 pathogenic changes. Eighty-nine percent of individuals with ALG8 mutations with imaging in the entire MCBB had kidney cysts (50%, >10 cysts), with greater median kidney and liver cyst numbers than controls. For ALG9, 78% had kidney cysts (27%, >10 cysts). Individuals with ALG8 mutations typically had mild cystic kidneys with limited enlargement. Liver cysts were common (71%), with enlarged livers (>2L) found in 11 of 62 patients, although surgical intervention was rare. The ALG9 kidney phenotype was also of mild cystic kidneys, but enlarged livers were rare; for both genes, CKD or kidney failure were rare.ConclusionsALG8 and ALG9 are defined as cystic kidney/liver genes but with limited penetrance for lower eGFR.
KW - ADPKD
KW - genetic diseases and development
KW - nephropathy
KW - polycystic kidney disease
UR - https://www.scopus.com/pages/publications/85217570785
U2 - 10.1681/ASN.0000000613
DO - 10.1681/ASN.0000000613
M3 - Article
C2 - 39899384
AN - SCOPUS:85217570785
SN - 1046-6673
VL - 36
SP - 1056
EP - 1071
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 6
ER -